| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.61▼ | 2.61▼ | 2.60▼ | 2.29▲ | 2.17▲ |
| MA10 | 2.61▼ | 2.58▲ | 2.43▲ | 2.37▲ | 1.96▲ |
| MA20 | 2.60▼ | 2.41▲ | 2.33▲ | 2.15▲ | 2.02▲ |
| MA50 | 2.40▲ | 2.38▲ | 2.40▲ | 1.89▲ | 1.50▲ |
| MA100 | 2.41▲ | 2.36▲ | 2.15▲ | 2.01▲ | 1.08▲ |
| MA200 | 2.28▲ | 1.99▲ | 1.94▲ | 1.67▲ | 1.47▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.015▼ | 0.028▲ | 0.046▲ | 0.010▲ | 0.034▲ |
| RSI | 56.818▲ | 61.324▲ | 63.614▲ | 66.131▲ | 60.103▲ |
| STOCH | 13.889▼ | 75.909 | 82.798▲ | 41.341 | 64.523 |
| WILL %R | -100.000▼ | -24.528▲ | -24.528▲ | -17.502▲ | -8.974▲ |
| CCI | -140.000▼ | 49.402 | 91.458 | 116.510▲ | 141.433▲ |
|
Monday, January 12, 2026 06:02 AM
Repeat-doses of DeltEx™ Drug-Resistant Immunotherapy gamma-delta (γδ) T cells (DRI) nearly doubled median progression-free survival (mPFS) to 13.0 months compared to only 6.6 months (+97%) in a ...
|
|
Friday, December 19, 2025 08:44 AM
(RTTNews) - IN8bio, Inc. (INAB), said on Friday, a biopharmaceutical company that's currently in clinical stages and working on T cell therapies for cancer and autoimmune diseases announced it had ...
|
|
Friday, December 19, 2025 04:59 AM
INB-619, IN8bio’s novel gamma-delta (“γδ”) T cell engager through an Investigational New Drug (“IND”) application Financing led by Coastlands Capital with participation from new and existing ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/01/26 | 2.31 | 2.73 | 2.265 | 2.59 | 236,622 |
| 15/01/26 | 2.22 | 2.50 | 2.17 | 2.32 | 123,013 |
| 14/01/26 | 2.15 | 2.31 | 2.15 | 2.21 | 71,096 |
| 13/01/26 | 2.21 | 2.24 | 2.12 | 2.17 | 78,511 |
| 12/01/26 | 2.34 | 2.35 | 2.10 | 2.18 | 152,166 |
| 09/01/26 | 2.35 | 2.55 | 2.2219 | 2.35 | 189,294 |
| 08/01/26 | 2.50 | 2.501 | 2.15 | 2.40 | 247,378 |
| 07/01/26 | 2.48 | 2.60 | 2.39 | 2.50 | 105,599 |
| 06/01/26 | 2.475 | 2.60 | 2.33 | 2.47 | 112,455 |
| 05/01/26 | 2.53 | 2.53 | 2.39 | 2.47 | 90,642 |
|
|
||||
|
|
||||
|
|